Red Light Therapy

What the evidence says

Red-light photobiomodulation exposes skin to non-ionizing red or near-infrared wavelengths at doses intended to alter cellular signaling without heating or injuring tissue. A systematic review of dermatologic LED trials described promising signals but emphasized small samples, heterogeneous devices, and inconsistent protocols.^[1]

Controlled facial-photoaging trials have reported improvements in wrinkles or collagen-related measures. An older split-face placebo-controlled trial and a newer sham-controlled home-mask trial both favored active light, while other larger studies compared two active wavelengths without a true sham and therefore cannot separate treatment from expectation or repeated measurement.^[2][3][4]

A result from one panel or mask does not validate every red-light product. Wavelength, irradiance, distance, treatment duration, total fluence, pulse pattern, heat, and treatment schedule can all differ, and consumer labels do not always provide enough information to reproduce a clinical protocol.^[1][5]

Short studies generally report mild transient redness, warmth, dryness, headache, or eye discomfort rather than serious skin injury. Eye protection is still important—especially with bright facial devices or anyone taking photosensitizing medication—and long-term surveillance is limited.^[5][6]